These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35689505)

  • 21. Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.
    Wang C; Venick RS; Shew SB; Dunn JCY; Reyen L; Gou R; Calkins KL
    JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):708-716. PubMed ID: 30411372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of different lipid emulsions on the lipid profile, fatty acid composition, and antioxidant capacity of preterm infants: A double-blind, randomized clinical trial.
    Wang Y; Feng Y; Lu LN; Wang WP; He ZJ; Xie LJ; Hong L; Tang QY; Cai W
    Clin Nutr; 2016 Oct; 35(5):1023-31. PubMed ID: 26561301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of liver function with two new/mixed intravenous lipid emulsions in children with intestinal failure.
    Pichler J; Simchowitz V; Macdonald S; Hill S
    Eur J Clin Nutr; 2014 Oct; 68(10):1161-7. PubMed ID: 24961544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and development of cholestasis in surgical neonates receiving an intravenous mixed-oil lipid emulsion.
    Yu LJ; Anez-Bustillos L; Mitchell PD; Ko VH; Secor JD; Hurley AP; Dao DT; Fligor SC; Cho BS; Tsikis ST; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):30-40. PubMed ID: 36308408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal Failure-Associated Liver Disease and Growth Pre- and Post-Transition to a Composite Lipid Emulsion.
    Hudson AS; Tyminski N; Turner JM; Silverman JA
    J Pediatr Gastroenterol Nutr; 2023 Jun; 76(6):830-836. PubMed ID: 36930972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parenteral Nutrition in the Neonatal Intensive Care Unit: Intravenous Lipid Emulsions.
    Chan AP; Rostas S; Rogers S; Martin CR; Calkins KL
    Clin Perinatol; 2023 Sep; 50(3):575-589. PubMed ID: 37536765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)--a double-blind, randomised, multicentre study in adults.
    Klek S; Chambrier C; Singer P; Rubin M; Bowling T; Staun M; Joly F; Rasmussen H; Strauss BJ; Wanten G; Smith R; Abraham A; Szczepanek K; Shaffer J
    Clin Nutr; 2013 Apr; 32(2):224-31. PubMed ID: 22796064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic dysfunction in patients receiving intravenous lipid emulsions.
    Miles JM
    Curr Opin Clin Nutr Metab Care; 2023 May; 26(3):278-283. PubMed ID: 36943142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical application of fish-oil intravenous lipid emulsion in adult home parenteral nutrition patients.
    Mundi MS; Bonnes SL; Salonen BR; McMahon MM; Martindale R; Hurt RT
    Nutr Clin Pract; 2021 Aug; 36(4):839-852. PubMed ID: 32970359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical effects of multi-oil versus pure soybean oil-based lipid emulsions for preterm infants: An observational study.
    Li X; Zhao R; Lv HF; Ying MF; Jiang Z
    Asia Pac J Clin Nutr; 2023; 32(1):77-84. PubMed ID: 36997489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of an Olive Oil-Based Lipid Emulsion Compared With a Soybean Oil-Based Lipid Emulsion on Liver Chemistry and Bile Acid Composition in Preterm Infants Receiving Parenteral Nutrition: A Double-Blind, Randomized Trial.
    Wang Y; Zhou KJ; Tang QY; Hong L; Feng Y; Lu LN; Wang WP; Cai W
    JPEN J Parenter Enteral Nutr; 2016 Aug; 40(6):842-50. PubMed ID: 25560678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-Dose Parenteral Soybean Oil for the Prevention of Parenteral Nutrition-Associated Liver Disease in Neonates With Gastrointestinal Disorders.
    Calkins KL; Havranek T; Kelley-Quon LI; Cerny L; Flores M; Grogan T; Shew SB
    JPEN J Parenter Enteral Nutr; 2017 Mar; 41(3):404-411. PubMed ID: 26024828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis.
    Lam HS; Tam YH; Poon TC; Cheung HM; Yu X; Chan BP; Lee KH; Lee BS; Ng PC
    Neonatology; 2014; 105(4):290-6. PubMed ID: 24576844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ESPGHAN Committee on Nutrition Position Paper. Intravenous Lipid Emulsions and Risk of Hepatotoxicity in Infants and Children: a Systematic Review and Meta-analysis.
    Hojsak I; Colomb V; Braegger C; Bronsky J; Campoy C; Domellöf M; Embleton N; Fidler Mis N; Hulst JM; Indrio F; Lapillonne A; Mihatsch W; Molgaard C; van Goudoever J; Fewtrell M;
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):776-92. PubMed ID: 26825766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children.
    Nandivada P; Baker MA; Mitchell PD; O'Loughlin AA; Potemkin AK; Anez-Bustillos L; Carlson SJ; Dao DT; Fell GL; Gura KM; Puder M
    Am J Clin Nutr; 2016 Sep; 104(3):663-70. PubMed ID: 27510535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma fatty acids in premature infants with hyperbilirubinemia: before-and-after nutrition support with fish oil emulsion.
    Klein CJ; Havranek TG; Revenis ME; Hassanali Z; Scavo LM
    Nutr Clin Pract; 2013 Feb; 28(1):87-94. PubMed ID: 23319354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triglycerides in fish oil affect the blood clearance of lipid emulsions containing long- and medium-chain triglycerides in mice.
    Qi K; Seo T; Jiang Z; Carpentier YA; Deckelbaum RJ
    J Nutr; 2006 Nov; 136(11):2766-72. PubMed ID: 17056798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An exclusively based parenteral fish-oil emulsion reverses cholestasis.
    Triana Junco M; García Vázquez N; Zozaya C; Ybarra Zabala M; Abrams S; García de Lorenzo A; Sáenz de Pipaón Marcos M
    Nutr Hosp; 2014 Oct; 31(1):514-6. PubMed ID: 25561149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous lipid emulsions and liver function in adult chronic intestinal failure patients: results from a randomized clinical trial.
    Klek S; Szczepanek K; Scislo L; Walewska E; Pietka M; Pisarska M; Pedziwiatr M
    Nutrition; 2018 Nov; 55-56():45-50. PubMed ID: 29960156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ASPEN Lipid Injectable Emulsion Safety Recommendations, Part 1: Background and Adult Considerations.
    Mirtallo JM; Ayers P; Boullata J; Gura KM; Plogsted S; Anderson CR; Worthington P; Seres DS; Nicolai E; Alsharhan M; Gutsul L; Mason AE
    Nutr Clin Pract; 2020 Oct; 35(5):769-782. PubMed ID: 32460429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.